University of Pennsylvania, BioNTech, and OUP Launch $50 Million Life Sciences Fund
The University of Pennsylvania (“Penn”), BioNTech SE (“BioNTech”), and OUP (Osage University Partners) announced the launch of the $50 million Penn-BioNTech Innovative Therapeutics Seed Fund (“PxB Fund”), a dedicated venture capital fund focused on early-stage life science companies originating from Penn. The joint effort will provide additional fuel to advance Penn discoveries into products that benefit patients across the world, following a decade in which the university’s research teams have spawned 45 FDA approvals for transformative vaccines and novel medical treatments such as CAR T cell therapy, and garnered a Nobel Prize and four Breakthrough Prizes for Life Sciences.
OUP Announces Promotions of Manny Stockman to Managing Partner, Mitra Miri to Partner, and Beth Grafstrom to SVP Finance
OUP (Osage University Partners), a venture capital firm that invests in startups commercializing breakthrough research, today announced the promotions of Manny Stockman, PhD, to Managing Partner, Mitra Miri, PhD, to Partner, and Beth Grafstrom to SVP Finance.
